05 Nov RNA-based precision medicine predicts sensitivity to selinexor in select pancreatic ductal adenocarcinoma patients
Posted at 14:01h
in INNOVATIVE THERAPIES
ID: 03081
Authors: Curiel-Garcia, Alvaro (1,2); Tomassoni, Lorenzo (2,3); Dalton, Tanner C. (1,2); Palermo, Carmine F. (1,2); Decker-Farrell, Amanda R. (1,2); Sastra, Steven A. (1,2); Wasko, Urzula N. (1,2); Ross, Daniel (1,2); Goncalves, Isabel M. (1,2); Mundi, Prabhot S. (2,3); Bakir, Basil S. (1,2); Safyan, Rachael A. (1); Hibshoosh, Hanina (4); Manji, Gulam A. (1); Califano, Andrea (2,3); Olive, Kenneth P. (1,2)
Topic: INNOVATIVE THERAPIES
Read